Drugs
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 03/24/17 -- VANC Pharmaceuticals Inc. ("VANC" or the "Company") (TSX VENTURE: VANC)(OTCQB: NUVPD), a pharmaceutical company focuse ...
SEATTLE, WA: SEATTLE, WA -- (Marketwired) -- 03/23/17 -- Atossa Genetics Inc. (NASDAQ: ATOS) today announced that it has opened enrollment of a Phase 1 study of endoxifen, which is an active metabolite of tamoxif ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 03/20/17 -- Quadron Capital Corp. (the "Company" or "Quadron") - (CSE: QCC)(CSE: QCC.CN) - is pleased to announce that it has clos ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 03/16/17 -- Knight Therapeutics Inc. (TSX: GUD) ("Knight" or the "Company"), a leading Canadian specialty pharmaceutical company, today repor ...
PARIS, ONTARIO: PARIS, ONTARIO -- (Marketwired) -- 03/13/17 -- Emblem Corp. (TSX VENTURE: EMC) ("Emblem" or the "Company") announced that the board of directors of the Company has approved the g ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 03/13/17 -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a leading Canadian specialty pharmaceutical company, announced today the commercial relaunc ...
PARIS, ONTARIO: PARIS, ONTARIO -- (Marketwired) -- 03/10/17 -- Emblem Corp. (TSX VENTURE: EMC) ("Emblem" or the "Company") is pleased to announce that it has retained the consulting services of ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 03/10/17 -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a leading Canadian specialty pharmaceutical company, will release its fourth quarter and ye ...
LAVAL, QUEBEC: LAVAL, QUEBEC -- (Marketwired) -- 03/08/17 -- Acasti Pharma Inc. (NASDAQ: ACST)(TSX VENTURE: ACST) today announced the appointment of Barry A. Franklin, Ph.D. and Robert Hegele, M.D. to its newly fo ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 03/08/17 -- Revive Therapeutics Ltd. ("Revive" or the "Company") (TSX VENTURE: RVV)(OTCQB: RVVTF), a company focused on the research, develop ...
Albany: Albany, New York, March 8, 2017: Epilepsy is a group of neurological diseases which is characterized by epileptic seizures. Epileptic seizures are occurrences that can range from short to long periods ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 02/27/17 -- VANC Pharmaceuticals Inc. ("VANC" or the "Company") (TSX VENTURE: VANC)(OTCQB: NUVPD), a pharmaceutical company focuse ...
LAVAL, QUEBEC: LAVAL, QUEBEC -- (Marketwired) -- 02/24/17 -- Acasti Pharma Inc. ("Acasti" or the "Corporation") (NASDAQ: ACST)(TSX VENTURE: ACST), today announced the grant of an aggregate of 1 ...
OTTAWA, ONTARIO: OTTAWA, ONTARIO -- (Marketwired) -- 02/24/17 -- CannaRoyalty Corp. (CSE: CRZ)(CSE: CRZ.CN)(OTCQB: CNNRF) ("CannaRoyalty") is pleased to announce that its strategic partner Natural Ventures ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 02/23/17 -- Knight Therapeutics Inc. (TSX: GUD) ("Knight") announced today (i) the resignation of Ed Schutter and (ii) the appointment Dr. Sarit Assoul ...
BUFFALO, NY: BUFFALO, NY -- (Marketwired) -- 02/22/17 -- (NASDAQ: CBLI) today reported financial results and development progress for the fourth quarter and year ended December 31, 2016.Cleveland BioLabs reported ...
ATLANTA, GEORGIA and MONTREAL, QUEBEC: ATLANTA, GEORGIA and MONTREAL, QUEBEC -- (Marketwired) -- 02/22/17 -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a leader in research, development and commercialization of prescription ophthal ...
CHICAGO, IL: CHICAGO, IL -- (Marketwired) -- 02/14/17 -- Cosmos Holdings, Inc. ("the Company") (OTCQB: COSM), an international pharmaceutical company, announced today that the Company acquired 100% of t ...
CHICAGO, IL: CHICAGO, IL -- (Marketwired) -- 02/07/17 -- Cosmos Holdings, Inc. ("the Company") (OTCQB: COSM), an international pharmaceutical company, announced that Orestes Varvitsiotes has been appoin ...
LAWRENCE, MA: Year End Review and a Look Forward to 2017 ...
